Search Results for: PCSK6

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ALPL alkaline phosphatase, biomineralization associated
  • Post-translational modification: synthesis of GPI-anchored proteins
  • Hypophosphatasia
CACNA1A calcium voltage-gated channel subunit alpha1 A
  • Presynaptic depolarization and calcium channel opening
  • Regulation of insulin secretion
  • Pregabalin
  • Spironolactone
  • Verapamil
  • Loperamide
  • Bepridil
  • Episodic ataxias
  • Familial or sporadic hemiplegic migraine
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
FLG filaggrin
  • Formation of the cornified envelope
  • Ichthyosis vulgaris
FN3K fructosamine 3 kinase
  • Gamma carboxylation, hypusine formation and arylsulfatase activation
IGF1R insulin like growth factor 1 receptor
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • IRS-related events triggered by IGF1R
  • SHC-related events triggered by IGF1R
  • Extra-nuclear estrogen signaling
  • Insulin Human
  • Insulin Lispro
  • Insulin Glargine
  • Insulin Pork
  • Mecasermin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • ATL1101
  • XL228
  • rhIGFBP-3
  • (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione
  • 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
  • Cixutumumab
  • Brigatinib
  • Malignant pleural mesothelioma
  • Synovial sarcoma
IL16 interleukin 16
  • Other interleukin signaling
PMCH pro-melanin concentrating hormone
  • Peptide ligand-binding receptors
  • G alpha (q) signalling events
  • G alpha (i) signalling events
RCN3 reticulocalbin 3
SNRPA1 small nuclear ribonucleoprotein polypeptide A'
  • mRNA Splicing - Major Pathway
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
SYNM synemin